1. MSBChem Consulting, Brisbane, Queensland, Australia
2. Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
3. Antimicrobial Resistance Division, WHO, Geneva, Switzerland
4. F2G Limited, Eccles, Manchester, United Kingdom
5. McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
6. Scientific Advisory Committee, GARDP, Geneva, Switzerland
7. The National Biodefense Science Board, U.S. Department of Health and Human Services, Washington, DC, USA
8. Center for Infectious Diseases Research, Houston Methodist Research Institute, Houston, Texas, USA
9. Center for Infectious Diseases, UTHealth School of Public Health, Houston, Texas, USA
10. Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel
11. The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
12. Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam
13. Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, Oxford University, Oxford, United Kingdom
14. Chemical Biology Ventures Ltd., Abingdon, Oxfordshire, United Kingdom
15. CARB-X, Boston University, Boston, Massachusetts, USA
16. Université de Montpellier, INSERM, Institut de Recherche pour le Développement, Montpellier, France
17. TB Alliance, New York, New York, USA
18. LL Silver Consulting, Springfield, New Jersey, USA
19. National Center for Global Health and Medicine, Tokyo, Japan
20. Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia
21. National Center for Infection Prevention, Swissnoso, Bern, Switzerland
22. Infection Control Programme, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center for Patient Safety, Geneva, Switzerland